Human alkaline ceramidase 3 (ACER3) is one of three alkaline ceramidases (ACERs) that catalyze the conversion of ceramide to sphingosine. ACERs are the members of the CREST superfamily of integralmembrane lipid hydrolases, including the adiponectin receptors which play roles in energy metabolism. All CREST members conserve a set of three Histidine, one Aspartate, and one Serine residue. However, the structural and catalytic roles for these residues are unclear. Here, we use ACER3 as a prototype enzyme to gain insight into this unique class of enzymes. Recombinant ACER3 was expressed in yeast cells that lack endogenous ceramidase activity, and microsomes were used for biochemical characterization. Six point mutantions of the conserved CREST motif were developed that are predicted to form a Zn-dependent active site based on homology with the human adiponectin receptors, whose crystal structures were recently determined. Five mutations completely lost their activity, except for S77A, which showed a 600-fold decrease compared with the wild-type enzyme. The activity of S77C mutation was pH sensitive, with neutral pH partially recovering ACER3 activity. This suggested a role for S77 in stabilizing the oxyanion of the transition state and differs from the proposed role in Zinc coordination for the adiponectin receptors (Vasiliauskaité-Brooks et. al., Nature, 2017). Together, these data suggest ACER3 is a Zn2+-dependent amidase that uses a catalytic mechanism for ceramide hydrolysis that is similar to other soluble Zn-based amidases. Consistent with this mechanism, ACER3 was specifically inhibited by trichostatin A, an HDAC inhibitor, which is a strong chelator of Zinc.
INTRODUCTION
Ceramidases catalyze the hydrolysis of ceramides to release free fatty acids and sphingosine (SPH). As such, they are important intermediates of complex sphingolipids that play an important role in the integrity and function of cell membranes 1 . Alkaline ceramidase 3 (ACER3) is one of three ACERs (ACER1, 2, and 3), which were cloned by our group 2 . ACER3 is localized to both the Golgi complex and endoplasmic reticulum (ER), and it is highly expressed in various tissues compared with the other two alkaline ceramidases. Additionally, it was demonstrated that ACER3 hydrolyzes a synthetic ceramide analogue NBD-C 12 -phytoceramide in vitro; thus, it was formerly named the human alkaline phytoceramidase (haPHC) 2 . Later, we reported that ACER3 catalyzes the hydrolysis of ceramides, dihydroceramides, and phytoceramides carrying an unsaturated long acyl chain (C18:1 or C20:1) with similar efficiency 3 . Recently, important roles of ACER3 in neurobiology have been highlighted. We demonstrated that ACER3 deficiency results in Purkinje cell degeneration in mice 4 and that a point mutation of ACER3 leads to progressive leukodystrophy in early childhood in humans 5 .
The sequence similarity between ACERs, and progestin and adipoQ receptors (PAQR receptors) was revealed by Villa et al. 6 . In turn, ACER3 has been reported to belong to a large superfamily of proteins referred to as CREST (for alkaline ceramidase, PAQR receptor, Per1, SID-1 and TMEM8) 7 . The CREST superfamily is highlighted in various cellular functions and biochemical activities. Ceramidases are lipid-modifying enzymes 8 . The PAQR receptors contain the adiponectin receptors, which regulate energy metabolism 9-11 .
The Per1 family consists of fatty acid remodeling hydrolases for GPI-anchored proteins [12] [13] . SID-1 family of putative RNA transporters is involved in systematic RNA interference [14] [15] . Lastly, the TMEM8 family is known to play a role in cancer biology as putative tumor suppressors [16] [17] .
All members of the CREST superfamily conserve a set of three Histidine residues, a Serine residue, and an Aspartate residue. These residues are the defining motif of the CREST family and were suggested to form a metal-dependent active site for lipid hydrolysis. However, the specific roles of the conserved residues in CREST proteins have not been reported. The independent discoveries of hydrolase activities in alkaline ceramidases 2, 18 and Per1 13 suggest that the majority of CREST members are metal-dependent hydrolases. In support of this, the adiponectin receptors were recently found to also hydrolyze ceramide, but at a slow rate 19 .
The crystal structures of the human adiponectin receptors (ADPR1 and ADPR2), which represent the first structures for any CREST member, were recently determined 20 , although there was a limitation of the study due to lack of presenting a direct catalytic approach. ADPR1 and ADPR2 exhibit a seven-transmembrane helix architecture with a zinc ion located near the end of a large internal cavity as the putative active site. Importantly, the zinc ion is coordinated by the three His residues of the CREST motif, and the conserved Ser and Asp residues are in close proximity to the Zinc ion. The His residues are required for activation of the adiponectin-stimulated pathways.
A catalytic mechanism for the ADPRs was recently proposed based on molecular dynamics simulations 19 . In this mechanism, the zinc coordinating residues were proposed to rearrange to facilitate ceramide hydrolysis. This mechanism differs quite drastically from other similar Zn-based amidases, such as HDACs, LpxC, peptide deformylase, matrix metalloproteinases (MMPs), and human neutral ceramidase [21] [22] [23] [24] . In all of these cases, the zinc coordinating residues do not rearrange and an Asp or His residue serves as a general base for catalysis.
Compared with the biological role of ACER3, which has been studied in the last decade, the kinetic mechanism of its intrinsic ceramidase activity has not been described in detail. Thus, there is little understanding of the catalytic properties of ACER3. In this study, our biochemical results and mutational analysis allow us to propose the mechanism for how ACER3 hydrolyzes ceramides, which most likely applies to other CREST members. Furthermore, the inhibitor assay exhibits a possibility to develop direct and specific inhibitors of ACER3 and its related paralogs, ACER1 and ACER2, for treatments of diseases associated with dysregulation of the metabolism of ceramides and other sphingolipids, such as cancers, diabetes mellitus, cardiovascular diseases, neurodegenerative diseases, and skin diseases [4] [5] [25] [26] .
EXPERIMENTAL PROCEDURES

Site-directed mutagenesis
The yeast expression plasmid pYES2-ACER3 that contains the FLAG-tagged open reading frame (ORF) of the wild-type ACER3 gene was constructed in our previous study 2, 18 and used as a template for sitedirected mutagenesis. The codon of His81, His217, His22, Asp92, Ser77 in the ACER3 ORF in pYES2-ACER3 (WT) was switched to a codon of Ala or Cys using QuickChange II XL a Site-Directed Mutagenesis Kit (Agilent Technology; Danbury, CT) following the manufacturer's manual. The resulting plasmids containing the mutated ORF was sequenced to confirm the codon switch.
Protein expression in yeast cells
The Saccharomyces cerevisiae mutant strain ∆ ypc1∆ydc1, in which both yeast alkaline ceramidase genes YPC1 and YDC1 was deleted 2 , was grown at 30°C on agar plates containing YPD medium (1% yeast extract, 2% peptone, 2% dextrose), or in liquid YPD medium with rotational shaking at 200 rpm.
∆ ypc1∆ydc1 cells were transformed with WT, H81A, H217A, H221A, D92A, S77A, and S77C, respectively, and the resulting transformants were selected on agar plates containing uracil-dropout synthetic medium (SC-Ura) with 2% glucose. ∆ ypc1∆ydc1 yeast cells transformed were grown in SC-Ura medium with 2% galactose to induce the expression of ACER3 or mutated ACER3s, respectively. Total membranes were prepared from yeast cells, and the expression of wild-type or mutanted ACER3s was determined by Western blot analyses using anti-FLAG antibody as described 18 .
Sample preparation and enzyme reaction for the ceramidase activity assays
The total membranes were collected from transformed yeast cells as described in 18 . Briefly, cells were harvested in log phage (at OD ≅ 1.0) and washed by PBS. Cells were broken by acid-washed beads and transferred to ultracentrifugation tubes. Then, all cell membranes were pelleted by ultracentrifugation (at 100,000 g for 1 hr with a TLA55 rotor, Beckman Coulter Life Sciences, Brea, CA) from post-nuclear cell lysates in Buffer A (25 mM Tris-HCl, pH 7.4, 0.25 M sucrose) supplemented with a protease inhibitor mixture (Roche, Indianapolis, IN). Membrane pellets were resuspended in Buffer B (25 mM Tris, pH7.4, 5 mM CaCl2 and 150 mM NaCl) by brief sonication.
Membrane homogenates (1 μ g of microsomal proteins) were measured for alkaline ceramidase activity using D-ribo -C 12 -NBD-phytoceramide (NBD-C 12 -PHC, Avanti, Alabaster, AL) as a substrate. Briefly, NBD-C 12 -PHC was dispersed by water bath sonication in Buffer C (25 mM glycine-NaOH, pH 9.4, 5 mM CaCl 2 , 150 mM NaCl, and 0.3% Triton X-100). The lipid-detergent mixtures were boiled for 30 s and chilled on ice immediately to form homogeneous lipid-detergent micelles, which were mixed with an equal volume of membranes suspended in Buffer B. Enzymatic reaction was carried out at 37 °C for 30 min, and the extraction buffer (chloroform: Methanol, 1:1) was added with 3 volumes of reaction mixture to quench the reactions. After centrifugation, the organic phase was collected and dried under a stream of inert nitrogen gas. Dried samples were dissolved in Mobile Phase B consisted of 1 mM ammonium formate in methanol containing 0.2% formic acid for high-performance liquid chromatography (HPLC).
High-performance liquid chromatography (HPLC)
HPLC was utilized to measure ceramidase activities and kinetics of ACER3 with a modification of the technique described in 27 . Ten μ L of each reaction was injected into reverse phase LC and separated by a Spectra C8SR Column (150 × 3.0 mm; 3 µm particle size; Peeke Scientific, Redwood City, CA). Mobile Phase A consisted of 2 mM ammonium formate in water containing 0.2% formic acid. Mobile Phase B consisted of 1 mM ammonium formate in methanol containing 0.2% formic acid. Fluorescence was determined using an 1100 Series HPLC-FLD Fluorescent Detector (Agilent, Santa Clara, CA) set to excitation and emission wavelengths of 467 and 540 nm, respectively. Fluorescent peaks were identified by comparing their retention times with NBD-C 12 -FA and NBD-C 12 -PHC (Fig. S3) . Calibration curves were calculated by linear regression. The data were exported to Excel spreadsheets to generate calibration lines and calculate sample concentrations.
ACER3 inhibitor assay
Before enzymatic reaction was performed, collected microsomes were pre-treated with inhibitors including DMSO (control), Trichostatin A (TSA, Sigma-Aldrich, St. Louis, MO) or C 6 -Cer-Urea (Avanti, Alabaster, AL) for 30 min. The lipiddetergent mixtures were then mixed with an equal volume of microsomes. Following incubation at 37 °C for 30 min, the reaction was terminated by adding the extraction buffer (chloroform/methanol, 1:1). Dried samples were dissolved in Mobile Phase B for HPLC.
Determination of kinetic constants
Kinetic constants were calculated from the Michaelis-Menten representations of at least three ACER3 activity assays, using different concentrations of NBD-C 12 -PHC (from 2.5 to 400 µM), and in the presence of protein amounts from 1 to 5 µg.
Protein expression analysis
Protein expression was assessed by Western blotting analyses using an anti-FLAG antibody (SigmaAldrich, St. Louis, MO) and anti-rabbit IgG (Cell Signaling Technology, Inc., Danvers, MA) secondary antibody.
RESULTS
To understand the catalytic mechanism of the CREST family of lipid hydrolases, it is important to relate the role of key active site residues with structural information. Alkaline ceramidases, which catalyze the hydrolysis of the amide bond of ceramide to form sphingosine and free fatty acid 2 ,
were the first members of CREST superfamily to be identified as lipid hydrolases. However, currently there is no available structural information for the alkaline ceramidases, which has hindered our understanding of their catalytic mechanism. It was previously demonstrated using a bioinformatics approach that ADPRs are related to alkaline ceramidases [19] [20] and belong to the CREST superfamily of lipid hydrolases 7 . Recently, the crystal structures of human ADPR1 and ADPR2 were determined. The ADPR structures revealed a 7-transmembrane architecture with a canonical Zndependent hydrolase active site located at the bottom of a central cavity 20 . While the ADPRs have been suggested to be lipid hydrolases, a robust biochemical assay to measure their activity is currently lacking. To determine the catalytic mechanism of the CREST superfamily, we sought to combine the structural information available for the ADPRs, with the biochemical assays available for alkaline ceramidases. We chose to focus our study on ACER3 due to its robust ability to hydrolyze the fluorescent lipid substrate NBD-C 12 -PHC, which can be easily quantitated, and the availability of a genetic mutation that could be used to verify structural models.
Model of human alkaline ceramidase 3 (ACER3).
To gain insight into the structure and function of alkaline ceramidases, a model of the ACER3 structure was generated using the Phyre2 webserver (http://www.sbg.bio.ic.ac.uk/~phyre2) based on the crystal structure of ADPR2 20 ( Fig. 1 ). Multiple sequence alignment was performed with the amino acid sequences of ACER1, ACER2, ACER3, ADPR1 and ADPR2 for comparison (Fig. 1D ). The majority of the model was predicted with high confidence with only small portions of the protein that corresponded to sites away from the active site predicted with lower confidence.
The ACER3 model consisted of a 7-transmembrane architecture with a central hydrophobic cavity similar to ADPRs. The twelve amino acids that are conserved with ADPRs were all clustered on the luminal side of ACER3, either present in the hydrophobic membrane-spanning segment or solvent exposed to the lumen. This included the key catalytic residues consisting of the three His residues involved in Zn-coordination, the Asp residue that hydrogen bonds to the Zn-bound water molecule, and the Ser residue of unknown function that is universally conserved in the CREST superfamily ( Fig. 1D ). Interestingly, Glu33 was predicted to hydrogen bond to the Zn-coordinating His217, which suggested that this residue is critical for stabilizing the active site (Fig. 1C ). This is consistent with the recently described point mutantion E33G, which inactivates ACER3 and causes a rare form of early childhood progressive leukodystrophy 5 . The remaining conserved residues were either clustered around the core catalytic residues and involved in transmembrane helix-helix stabilizing interactions or were solvent exposed in the lumen.
We also analyzed the position of the residues absolutely conserved among alkaline ceramidases, but not conserved with ADPRs. The majority of these residues were clustered around the key catalytic residues within the active site, which suggests they may play a role in binding and recognizing ceramide. Interestingly, there were only a few residues conserved within the upper portion of the hydrophobic cavity. The general lack of conservation in this region may be due to the specific preference of each ACER for different fattyacyl chain lengths of ceramide, which is predicted to bind within this hydrophobic cavity. Overall, our model of ACER3 suggests that essential amino acids in the catalytic site are well conserved between ACER3 and ADPRs and suggests that ACER3 is a Zn 2+ -dependent amidase.
Kinetic Characterization of wild-type and mutated ACER3. To investigate the kinetics of ACER3 ceramidase activity, we used a previously established microsomal assay in conjunction with a newly established HPLC assay with improved sensitivity. First, microsomes were purified from S. cerevisiae cells (∆Ydc1∆Ypc1) overexpressing human ACER3. Since S. cerevisiae has only two ceramidases, Ypc1p and Ydc1p,
Δ
Ypc1ΔYdc1 cells lack all endogenous ceramidase activity and thus provide the ideal signal to noise ratio to analyze ceramidase activity 2, 28 . In accordance with previous studies 2, 18 , the ceramidase activity of ACER3
toward NBD-C 12 -PHC was determined at pH 9.4, unless otherwise mentioned. Prior to determining the enzyme kinetics of ACER3, the linear detection limit of the product NBD-fatty acid was determined (Fig.  S1 ). This newly established method was extremely sensitive and could quantitate NBD-FA levels at far lower levels than our previous TLC based method. In addition, the time and protein concentration for the reaction were optimized and confirmed to be in the linear range ( Our model of ACER3 identified a canonical Znamidase active site that included three Zncoordinating His residues and an Asp residue that was hydrogen-bonding with a Zn-bound water. To test the hypothesis that ACER3 is a Zn-dependent amidase, we investigated the importance of each active residue of ACER3 by site-directed mutagenesis. Each residue was replaced with Ala to make the point mutations of ACER3 including H81A, H217A, H221A, and D92A. The expression levels of wild-type and all mutated ACER3 were verified to be similar by western blot (Fig. 2B) . Ceramidase activities of wild-type and the four point mutations toward NBD-C 12 -PHC were measured by HPLC (Fig. 2C) . Ceramidase activity was not detected in all of the mutations. This suggested these residues were all essential for ACER3 to catalyze the hydrolysis of NBD-C12-PHC.
Mutational analysis of Ser77. Unlike other Zndependent amidases, ACER3 contains a unique serine residue located near the Zn 2+ ion in the active site. This Ser residue is universally conserved in ADPRs and the CREST superfamily and is part of the motif that defines this protein superfamily. However, the role of S77 is unclear as other Zndependent amidases do not contain a Ser residue in their active site. To ascertain the role of Ser77, we used site-direct mutagenesis to replace Ser77 with Ala (S77A) and determined the effect on ACER3 ceramidase activity. Interestingly, S77A had a low but measurable ceramidase activity that was approximately 600-fold lower than WT ACER3 (Fig.  2C ). The reaction of S77A followed MichaelisMenten kinetics with a dramatically reduced V max (0.061 vs. 47 pmol/min/mg) that was accompanied by a slight increase in K M from 15.5
To further investigate the role of Ser77, we generated the point mutation S77C using sitedirected mutagenesis. This point mutation was chosen because we reasoned that the thiol group (-SH) of cysteine might be able to complement the hydroxyl group (-OH) of serine. However, the S77C ACER3 point mutation had no measurable alkaline ceramidase activity. Since the pKa of the cysteine thiol group is 8.14 and we conducted our analysis at the ACER3 pH optima of 9.4. we evaluated if lowering the pH to 7.5, which would protonate the thiol group and eliminate the negative charge, would be sufficient to restore some ACER3 activity ( Fig.  3B and 3C) . Interestingly, decreasing the pH to 7.5 showed a notable increase of S77C activity, equivalent to the S77A mutation. At pH 7.5, wildtype ACER3 had a slight 7% reduction of activity and there were no measurable effects on all other mutations (Fig. 3C ). Since the recovered activity of S77C was very low, we measured the enzyme kinetics of S77C to validate if the recovered activity of S77C comes from ACER3 enzyme reaction (Fig.  3B) (Fig. 4A) . Only TSA treatment inhibited the activity in a concentration dependent manner. To determine the mechanism of inhibition of TSA, we performed kinetic assays. As seen in Figure 4B , TSA treatment had no effect on the K M (K M = 15.89 ± 1.077 μ M) but reduced the V MAX (V MAX = 31.53 ± 0.493 pmol/min/mg) of ACER3. This is indicative of an non-competitive mechanism of inhibition (Fig.  4B) .
DISCUSSION
Based on the predicted model of ACER3 and our mutational analysis, we propose a general acid-base catalysis mechanism for ceramide hydrolysis by ACER3. By our suggested mechanism, Asp92 is predicted to activate the water molecule by deprotonation, serving as a general base (Fig. 5) . The activated water molecule undergoes a nucleophilic attack on the amide bond resulting in the formation of an oxyanion bound to a tetrahedral carbon. The terminal amine of the sphingosine moiety is predicted to abstract the proton from Asp92, resulting in the collapse of the tetrahedral carbon intermediate, releasing sphingosine and a fatty acid. Finally, the protein catalyst is regenerated.
Consistent with this mechanism, the mutations of the three proximal Zn-coordinating residues (His81, His217, and His221) and Asp92 abolished ACER3 activity (Fig. 2C) . Additionally, substitutions of Ser77 dramatically decreased ACER3 ceramidase activity suggesting the important role of Ser77. Ser77 is predicted to form a hydrogen bond with the oxygen of carbonyl from the amide bond of ceramide, to help position the amide bond of ceramide for nucleophilic attack by the water molecule. Ser77 is also predicted to stabilize the negatively charged oxyanion of the transition state. The proposed role of Ser77 is supported by the pH dependence of the S77C mutation ( Fig. 3B and 3C ). At alkaline pH the cysteine residue is unprotonated and negatively charged, thus it would be unable to hydrogen bond with the oxygen carbonyl and would interact unfavorably with the negatively charged oxyanion. Overall, our proposed mechanism identifies key roles for all the universally conserved residues of the CREST superfamily in the active site of ACER3. Importantly, our proposed mechanism does not involve rearrangement of the Zinc-coordinating residues as proposed for ADPRs 19 . In the proposed ADPR mechanism, the conserved Ser residue is proposed to be involved in ceramide hydrolysis. To be specific, they suggest that the rearrangement of the zinc binding site upon ceramide binding can lead to the direct coordination of Ser77 hydroxyl to the zinc. However, the low, but the measurable activity of the S77A and S77C mutations is not consistent with a role for the conserved Ser in metal coordination. Based on the pH sensitivity, it appears it is most likely involved in aiding stabilization of the transition state oxyanion. 15.5 ± 1.2 46.9 ± 0.9 TSA (60 μM) 15.9 ± 1.1 31.5 ± 0.5
